Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIH Genome Institute makes two leadership appointments

This article was originally published in Scrip

Executive Summary

The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, has appointed two senior staff to leadership positions. Dr Mark Guyer, currently director of NHGRI's division of extramural research, has been appointed deputy director of the institute, and Dr James Mullikin, currently acting director of the NIH Intramural Sequencing Center, has been kept on as its permanent director. Dr Guyer has served at NHGRI for 23 years, and Dr Mullikin joined the NIH in 2003.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC014383

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel